![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: PIP4K2C |
Gene summary for PIP4K2C |
![]() |
Gene information | Species | Human | Gene symbol | PIP4K2C | Gene ID | 79837 |
Gene name | phosphatidylinositol-5-phosphate 4-kinase type 2 gamma | |
Gene Alias | PIP5K2C | |
Cytomap | 12q13.3 | |
Gene Type | protein-coding | GO ID | GO:0000045 | UniProtAcc | B3KQV3 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
79837 | PIP4K2C | LZE4T | Human | Esophagus | ESCC | 1.37e-09 | 2.11e-01 | 0.0811 |
79837 | PIP4K2C | LZE7T | Human | Esophagus | ESCC | 4.08e-11 | 4.36e-01 | 0.0667 |
79837 | PIP4K2C | LZE8T | Human | Esophagus | ESCC | 1.42e-03 | 1.60e-01 | 0.067 |
79837 | PIP4K2C | LZE20T | Human | Esophagus | ESCC | 1.53e-03 | 1.68e-01 | 0.0662 |
79837 | PIP4K2C | LZE22T | Human | Esophagus | ESCC | 2.82e-03 | 2.68e-01 | 0.068 |
79837 | PIP4K2C | LZE24T | Human | Esophagus | ESCC | 1.48e-15 | 4.61e-01 | 0.0596 |
79837 | PIP4K2C | LZE21T | Human | Esophagus | ESCC | 6.49e-04 | 2.82e-01 | 0.0655 |
79837 | PIP4K2C | LZE6T | Human | Esophagus | ESCC | 9.76e-03 | 1.64e-01 | 0.0845 |
79837 | PIP4K2C | P1T-E | Human | Esophagus | ESCC | 2.82e-04 | 2.73e-01 | 0.0875 |
79837 | PIP4K2C | P2T-E | Human | Esophagus | ESCC | 5.50e-15 | 3.47e-01 | 0.1177 |
79837 | PIP4K2C | P4T-E | Human | Esophagus | ESCC | 1.27e-12 | 2.51e-01 | 0.1323 |
79837 | PIP4K2C | P5T-E | Human | Esophagus | ESCC | 3.90e-12 | 2.71e-01 | 0.1327 |
79837 | PIP4K2C | P8T-E | Human | Esophagus | ESCC | 1.97e-14 | 3.72e-01 | 0.0889 |
79837 | PIP4K2C | P9T-E | Human | Esophagus | ESCC | 1.27e-02 | 1.49e-01 | 0.1131 |
79837 | PIP4K2C | P10T-E | Human | Esophagus | ESCC | 5.10e-10 | 1.58e-01 | 0.116 |
79837 | PIP4K2C | P11T-E | Human | Esophagus | ESCC | 4.25e-05 | 4.25e-01 | 0.1426 |
79837 | PIP4K2C | P12T-E | Human | Esophagus | ESCC | 1.63e-17 | 3.19e-01 | 0.1122 |
79837 | PIP4K2C | P15T-E | Human | Esophagus | ESCC | 7.74e-18 | 4.03e-01 | 0.1149 |
79837 | PIP4K2C | P16T-E | Human | Esophagus | ESCC | 1.67e-10 | 1.93e-01 | 0.1153 |
79837 | PIP4K2C | P17T-E | Human | Esophagus | ESCC | 1.10e-10 | 4.94e-01 | 0.1278 |
Page: 1 2 3 4 5 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:001623617 | Esophagus | ESCC | macroautophagy | 216/8552 | 291/18723 | 1.94e-23 | 4.57e-21 | 216 |
GO:0009896111 | Esophagus | ESCC | positive regulation of catabolic process | 332/8552 | 492/18723 | 4.36e-23 | 9.22e-21 | 332 |
GO:0031331111 | Esophagus | ESCC | positive regulation of cellular catabolic process | 292/8552 | 427/18723 | 8.67e-22 | 1.53e-19 | 292 |
GO:001050617 | Esophagus | ESCC | regulation of autophagy | 220/8552 | 317/18723 | 6.72e-18 | 6.36e-16 | 220 |
GO:0010563111 | Esophagus | ESCC | negative regulation of phosphorus metabolic process | 274/8552 | 442/18723 | 2.32e-12 | 9.41e-11 | 274 |
GO:0045936111 | Esophagus | ESCC | negative regulation of phosphate metabolic process | 273/8552 | 441/18723 | 3.18e-12 | 1.25e-10 | 273 |
GO:000703314 | Esophagus | ESCC | vacuole organization | 127/8552 | 180/18723 | 1.04e-11 | 3.85e-10 | 127 |
GO:0051348111 | Esophagus | ESCC | negative regulation of transferase activity | 177/8552 | 268/18723 | 1.08e-11 | 4.00e-10 | 177 |
GO:001624114 | Esophagus | ESCC | regulation of macroautophagy | 102/8552 | 141/18723 | 1.09e-10 | 3.27e-09 | 102 |
GO:0042326111 | Esophagus | ESCC | negative regulation of phosphorylation | 237/8552 | 385/18723 | 1.86e-10 | 5.33e-09 | 237 |
GO:003367319 | Esophagus | ESCC | negative regulation of kinase activity | 154/8552 | 237/18723 | 1.38e-09 | 3.27e-08 | 154 |
GO:00086544 | Esophagus | ESCC | phospholipid biosynthetic process | 162/8552 | 253/18723 | 2.59e-09 | 5.73e-08 | 162 |
GO:00464744 | Esophagus | ESCC | glycerophospholipid biosynthetic process | 135/8552 | 211/18723 | 5.75e-08 | 1.02e-06 | 135 |
GO:190503712 | Esophagus | ESCC | autophagosome organization | 73/8552 | 103/18723 | 1.88e-07 | 2.93e-06 | 73 |
GO:00450175 | Esophagus | ESCC | glycerolipid biosynthetic process | 154/8552 | 252/18723 | 5.20e-07 | 6.96e-06 | 154 |
GO:000004513 | Esophagus | ESCC | autophagosome assembly | 69/8552 | 99/18723 | 1.10e-06 | 1.38e-05 | 69 |
GO:190165319 | Esophagus | ESCC | cellular response to peptide | 208/8552 | 359/18723 | 1.68e-06 | 2.01e-05 | 208 |
GO:190211514 | Esophagus | ESCC | regulation of organelle assembly | 116/8552 | 186/18723 | 3.15e-06 | 3.53e-05 | 116 |
GO:0043434111 | Esophagus | ESCC | response to peptide hormone | 234/8552 | 414/18723 | 4.93e-06 | 5.21e-05 | 234 |
GO:00066446 | Esophagus | ESCC | phospholipid metabolic process | 218/8552 | 383/18723 | 5.37e-06 | 5.59e-05 | 218 |
Page: 1 2 3 4 5 6 7 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa0481028 | Esophagus | ESCC | Regulation of actin cytoskeleton | 133/4205 | 229/8465 | 5.94e-03 | 1.48e-02 | 7.56e-03 | 133 |
hsa04810112 | Esophagus | ESCC | Regulation of actin cytoskeleton | 133/4205 | 229/8465 | 5.94e-03 | 1.48e-02 | 7.56e-03 | 133 |
hsa0481041 | Liver | HCC | Regulation of actin cytoskeleton | 134/4020 | 229/8465 | 4.48e-04 | 1.94e-03 | 1.08e-03 | 134 |
hsa0481051 | Liver | HCC | Regulation of actin cytoskeleton | 134/4020 | 229/8465 | 4.48e-04 | 1.94e-03 | 1.08e-03 | 134 |
hsa0481026 | Oral cavity | OSCC | Regulation of actin cytoskeleton | 129/3704 | 229/8465 | 7.14e-05 | 2.74e-04 | 1.40e-04 | 129 |
hsa04810111 | Oral cavity | OSCC | Regulation of actin cytoskeleton | 129/3704 | 229/8465 | 7.14e-05 | 2.74e-04 | 1.40e-04 | 129 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
PIP4K2C | SNV | Missense_Mutation | novel | c.586G>A | p.Glu196Lys | p.E196K | Q8TBX8 | protein_coding | tolerated(0.79) | benign(0.028) | TCGA-FI-A2D0-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
PIP4K2C | SNV | Missense_Mutation | novel | c.406N>T | p.Gly136Cys | p.G136C | Q8TBX8 | protein_coding | deleterious(0) | probably_damaging(0.998) | TCGA-FI-A2F4-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
PIP4K2C | insertion | Frame_Shift_Ins | novel | c.50_51insC | p.Gly19ArgfsTer43 | p.G19Rfs*43 | Q8TBX8 | protein_coding | TCGA-EY-A548-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | ||
PIP4K2C | SNV | Missense_Mutation | novel | c.1159N>A | p.His387Asn | p.H387N | Q8TBX8 | protein_coding | deleterious(0.03) | probably_damaging(0.969) | TCGA-DD-AACD-01 | Liver | liver hepatocellular carcinoma | Male | <65 | I/II | Unknown | Unknown | PD |
PIP4K2C | SNV | Missense_Mutation | c.237N>A | p.Ser79Arg | p.S79R | Q8TBX8 | protein_coding | tolerated(0.14) | benign(0.174) | TCGA-05-4382-01 | Lung | lung adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD | |
PIP4K2C | SNV | Missense_Mutation | novel | c.440N>T | p.Arg147Leu | p.R147L | Q8TBX8 | protein_coding | deleterious(0.02) | benign(0.124) | TCGA-05-4396-01 | Lung | lung adenocarcinoma | Male | >=65 | III/IV | Unknown | Unknown | SD |
PIP4K2C | SNV | Missense_Mutation | novel | c.744N>C | p.Lys248Asn | p.K248N | Q8TBX8 | protein_coding | tolerated(0.37) | benign(0.006) | TCGA-49-AARO-01 | Lung | lung adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | PD |
PIP4K2C | SNV | Missense_Mutation | novel | c.440N>T | p.Arg147Leu | p.R147L | Q8TBX8 | protein_coding | deleterious(0.02) | benign(0.124) | TCGA-55-6971-01 | Lung | lung adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
PIP4K2C | SNV | Missense_Mutation | novel | c.877N>T | p.Gly293Cys | p.G293C | Q8TBX8 | protein_coding | deleterious(0) | probably_damaging(0.95) | TCGA-69-A59K-01 | Lung | lung adenocarcinoma | Female | <65 | I/II | Chemotherapy | cisplatin | SD |
PIP4K2C | SNV | Missense_Mutation | c.490N>T | p.Ser164Cys | p.S164C | Q8TBX8 | protein_coding | deleterious(0.04) | probably_damaging(0.926) | TCGA-86-8073-01 | Lung | lung adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |